RetroSense Therapeutics, LLC — Form D/A
RetroSense Therapeutics, LLC of ANN ARBOR, MI, a company, filed a Form D amendment with the SEC on 2015-10-13. The offering totals $5.0M, of which $4.6M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2015-10-13
- Form: D/A
- Accession: 0001520439-15-000004
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $4.6M
- Remaining: $438K
- Minimum investment: $4
- Investors: 22
- Date of first sale: 2015-08-19
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-246735
Issuer
- Name: RetroSense Therapeutics, LLC
- CIK: 0001520439
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 330 E. LIBERTY STREET, ANN ARBOR, MI, 48104
- Phone: 734-369-9333
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Sean Ainsworth | Director | Farmington Hills, MI |
| Terry Cross | Director | Rochester Hills, MI |
| Cam Gallagher | Director | San Diego, CA |
| Kenneth Kousky | Director | Freeland, MI |
| George Lasezkay | Director | Alpharetta, GA |
| Sean Ainsworth | Executive Officer | Farmington Hills, MI |
Other filings by this issuer (2)
More